Aerie Pharma (AERI) Misses Q1 EPS by 18c

Aerie Pharma (NASDAQ: AERI) reported Q1 EPS of ($1.05), $0.18 worse than the analyst estimate of ($0.87).

As of March 31, 2018, Aerie had cash, cash equivalents and investments of $334.0 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance